NASDAQ:VRPX

Virpax Pharmaceuticals Stock Predictions

Healthcare > Biotechnology

Buy VRPX

*Your capital is at risk

$0.0001

+0 (+0%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

VRPX Prediction Chart

VRPX Predictions History

Latest community submissions for VRPX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
savannahgeorgia5164.382325	Feb 18, 2025	Bullish	$0.310	X	—	0
PredictionBot.Kathy Pro	Feb 18, 2025	$0.308 -96.22%	$0.310	V	99.41%	4
PredictionBot.Warren Pro	Feb 18, 2025	$0.315 -96.14%	$0.310	V	98.40%	1
iamsameer06	Feb 18, 2025	$0.600 -92.65%	$0.310	X	6.45%	0
danny.vandewinkel74	Feb 18, 2025	Bullish	$0.310	X	—	0
PredictionBot.Warren Pro	Apr 29, 2024	$3.19 -95.88%	$2.77	X	84.78%	0
Skagitqg Merchant	Apr 29, 2024	Bullish	$2.77	X	—	0
jkikdoo.288347	Dec 31, 2021	Bullish	$3.43	X	—	1
JS Pro	Sep 14, 2021	$8.64 -99.44%	$6.16	V	59.74%	1
RamboRex3000 Pro	Aug 18, 2021	$19.82 -99.65%	$22.90	X	86.55%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VRPX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT VIRPAX PHARMACEUTICALS, INC.

Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical nonsteroidal anti-inflammatory drug treatment for chronic osteoarthritis of the knee; Probudur, an inject...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by